Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Roshanthi Eranga Karunaratne"'
Use of nanotechnology for infectious disease diagnostics: application in drug resistant tuberculosis
Autor:
Roshanthi Eranga Karunaratne, Lahiru A. Wijenayaka, Sandya Sulochana Wijesundera, K. M. Nalin De Silva, Chamila Priyangani Adikaram, Jennifer Perera
Publikováno v:
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background The increased transmission of multidrug-resistant (MDR) tuberculosis (TB) poses a challenge to tuberculosis prevention and control in Sri Lanka. Isoniazid (INH) is a key element of the first line anti tuberculosis treatment regime
Externí odkaz:
https://doaj.org/article/9d448d72487a4e7b879b011cc7c66067
Autor:
Chamila Priyangani Adikaram, Jennifer Perera, Galbokka Hewage Roshanthi Eranga Karunaratne, Sandhya Sulochana Wijesundera, Dhammika Vidanagama
Publikováno v:
Microbial Drug Resistance. 24:844-851
The emergence and spread of drug-resistant tuberculosis (TB) pose a threat to TB control in Sri Lanka. Isoniazid (INH) is a key element of the first-line anti-TB treatment regimen. Resistance to INH is mainly associated with point mutations in katG,
Use of nanotechnology for infectious disease diagnostics: application in drug resistant tuberculosis
Autor:
Sandya Sulochana Wijesundera, Lahiru A. Wijenayaka, Jennifer Perera, Chamila Priyangani Adikaram, Roshanthi Eranga Karunaratne, K.M. Nalin de Silva
Publikováno v:
BMC Infectious Diseases
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-9 (2019)
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-9 (2019)
Background The increased transmission of multidrug-resistant (MDR) tuberculosis (TB) poses a challenge to tuberculosis prevention and control in Sri Lanka. Isoniazid (INH) is a key element of the first line anti tuberculosis treatment regimen. Resist